Revisiting inflammation in diabetic nephropathy: The role of The Nlrp3 inflammasome in glomerular resident cells

Kidney International

Volumn 87, Issue 1, 2015, Pages 12-14

  Sakai, Norihiko ^a   Wada, Takashi ^b  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIOXIDANT; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CRYOPYRIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; LECTIN; NUCLEOTIDE BINDING PROTEIN; PATTERN RECOGNITION RECEPTOR; REACTIVE OXYGEN METABOLITE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; INFLAMMASOME; CARRIER PROTEIN;

ALBUMINURIA; ANTIOXIDANT ACTIVITY; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; JUXTAGLOMERULAR CELL; LYMPHOCYTIC INFILTRATION; MITOCHONDRION; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; GLOMERULAR RESIDENT CELL; IMMUNOCOMPETENT CELL; KIDNEY CELL; NOTE; PRIORITY JOURNAL; PROTEIN TARGETING; ANIMAL; CYTOLOGY; GLOMERULUS; IMMUNOLOGY;

ANIMALS; CARRIER PROTEINS; DIABETIC NEPHROPATHIES; HUMANS; INFLAMMASOMES; KIDNEY GLOMERULUS;

EID: 84920183179     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.322     Document Type: Note

References (10)

1. Awad AS, Kinsey GR, Khutsishvili K et al. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am J Physiol Renal Physiol 2011; 301: F1358-F1366.
2. Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738-749.
3. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
4. Turner CM, Arulkumaran N, Singer M et al. Is The inflammasome a potential therapeutic target in renal disease? BMC Nephrol [online] 2014; 15: 21.
5. Nakamura A, Shikata K, Hiramatsu M et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2005; 28: 2890-2895.
6. Lee SH, Ihm CG, Sohn SD et al. Polymorphisms in interleukin-1 beta and interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am J Nephrol 2004; 24: 410-414.
7. Shahzad K, Bock F, Dong W et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int 2015; 87: 74-84.
8. Zhang C, Boini KM, Xia M et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension 2012; 60: 154-162.
9. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-225.
10. Coughlan MT, Thorburn DR, Penfold SA et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol 2009; 20: 742-752.